MHA

Manhattan Pharmaceuticals (MHA)

Manhattan Pharmaceuticals

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:MHA

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2008/03/20	01 : 35	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc-Amended Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/re.. (25/A)	AMEX:MHA	Manhattan Pharmaceuticals
2008/03/11	03 : 14	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc-Nat'nl Sec. Exchg. Report the Removal from listing & reg. of matured, redeemed/retired sec. (25)	AMEX:MHA	Manhattan Pharmaceuticals
2008/03/06	06 : 19	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)	AMEX:MHA	Manhattan Pharmaceuticals
2008/02/29	04 : 43	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
2008/02/14	07 : 12	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)	AMEX:MHA	Manhattan Pharmaceuticals
2008/02/07	07 : 00	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
2008/01/04	04 : 56	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
2007/12/10	21 : 07	Business Wire	AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance with Continued Listing Standards	AMEX:MHA	Manhattan Pharmaceuticals
2007/11/15	00 : 00	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Quarterly Report (10-Q)	AMEX:MHA	Manhattan Pharmaceuticals
2007/10/04	05 : 02	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
2007/10/04	05 : 02	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc - Current report filing (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
2007/09/22	03 : 35	Edgar (US Regulatory)	Manhattan Pharmaceuticals Inc (Other) (8-K)	AMEX:MHA	Manhattan Pharmaceuticals
2007/07/10	20 : 00	PR Newswire (US)	Manhattan Pharmaceuticals Provides Update on Clinical Pipeline	AMEX:MHA	Manhattan Pharmaceuticals
2007/07/10	05 : 30	PR Newswire (US)	Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone	AMEX:MHA	Manhattan Pharmaceuticals
2007/06/27	21 : 59	PR Newswire (US)	Manhattan Pharmaceuticals Acquires Hedrin(TM) for the Treatment of Head Lice	AMEX:MHA	Manhattan Pharmaceuticals
2007/05/10	22 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Successfully Completes Dosing Portion of Two Phase 2a Clinical Trials of Oral Oleoyl-estrone for Obesi	AMEX:MHA	Manhattan Pharmaceuticals
2007/04/04	22 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Announces License Agreement and Expanded Pipeline	AMEX:MHA	Manhattan Pharmaceuticals
2007/04/02	22 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Completes $8.6 Million Private Placement	AMEX:MHA	Manhattan Pharmaceuticals
2007/03/27	22 : 29	PR Newswire (US)	AMEX Accepts Manhattan Pharmaceuticals' Plan to Regain Compliance With Continued Listing Standards	AMEX:MHA	Manhattan Pharmaceuticals
2007/02/21	22 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Completes Enrollment in Phase 2a Study of Oral Oleoyl-estrone for Obesity	AMEX:MHA	Manhattan Pharmaceuticals
2006/11/08	22 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to US	AMEX:MHA	Manhattan Pharmaceuticals
2006/11/08	22 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Expands Phase 2a Obesity Clinical Trial Sites to US	AMEX:MHA	Manhattan Pharmaceuticals
2006/10/12	22 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Expanding Oral Oleoyl-estrone Clinical Program to Include Morbidly Obese	AMEX:MHA	Manhattan Pharmaceuticals
2006/06/30	00 : 29	PR Newswire (US)	Manhattan Pharmaceuticals Doses First Patient Group In Phase IIa Trial For OE, Its Oral Obesity Drug Candidate	AMEX:MHA	Manhattan Pharmaceuticals
2006/05/16	22 : 02	PR Newswire (US)	Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate	AMEX:MHA	Manhattan Pharmaceuticals
2005/12/29	01 : 25	PR Newswire (US)	Manhattan Pharmaceuticals' Topical Psoriasis Treatment in Phase IIa Trial	AMEX:MHA	Manhattan Pharmaceuticals
2005/10/08	02 : 35	PR Newswire (US)	American Stock Exchange Lists Common Stock of Manhattan Pharmaceutical Inc.	AMEX:MHA